New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

EAS offers regulatory advice at Vitafoods South America

EAS offers regulatory advice at Vitafoods South America

EAS Strategic Advice will be offering free one-on-one tailored regulatory advice sessions to companies on nutritional products at Vitafoods South America 2014 in Brazil.

At the Transamerica Expo Centre in Sao Paolo, on April 8 to 9, the experts in international regulation will give regulatory advice on labelling, claims, market access and formula compliance, with the aim of helping companies to best market their product across Latin America.

These free 20-minute sessions can be booked in advance on the Vitafoods South America website: vitafoodssouthamerica.com.

“Certainly, one of the most important areas in process of update and development is the area of claims. The considerable investment on research and the advance of science in this field explain how dynamic rules on the communication of beneficial effects of nutritional products are,” said Clara Giudice, regulatory affairs manager. “Health claims serve as the base of information to consumers about the benefits of foods. Our advice sessions aim to help companies make a better use of the opportunities arising from the development and update of this framework, as well as guide companies with other regulatory issues of relevance for the industry.”

Vitafoods South America is the region's leading nutraceutical and functional foods event, where participants can meet companies producing or supplying ingredients and raw material, functional foods and beverages, and source new products in the market of food supplements. 

 

DSM to launch new antioxidant, omega-3 ingredients

DSM to launch new antioxidant, omega-3 ingredients

DSM will showcase its broad portfolio of nutritional solutions at this year’s Vitafoods. Committed to providing its customers with a wide range of ingredients to support a variety of health benefits, DSM’s latest innovations include elaVida, an antioxidant naturally found in olive fruits and life’sOmega60, a high potency DHA/EPA oil. The new launches offer benefits to heart, joint, brain and eye health, amongst others. As ever, Vitafoods will provide the opportunity not only to discover DSM’s new products but also to get updated on the latest science. DSM’s expert and senior vice president of nutrition science and advocacy, Dr. Manfred Eggersdorfer, will be on stand on May 6 to discuss the most recent innovative science news on the well-known vitamin E with individual guests.

DSM’s elaVida promises to be a highlight of the Vitafoods show. elaVida is a versatile olive polyphenol made from olives with a proprietary solvent-free process. Containing the powerful antioxidant hydroxytyrosol, elaVida supports heart health through the protection of blood lipids from oxidative stress. Literature also indicates that olive polyphenols may have a beneficial effect in joint health, cellular energy metabolism and helping boost the body’s own antioxidant system. Karin Wertz, Innovation Project Manager at DSM, will be presenting a seminar on elaVida at 10.30 am on Tuesday, May 6.

DSM will also be introducing life’sOmega 60, a new, even higher potency form of life’sOmega, which will be marketed as a 60 percent total omega-3 product for dietary supplements. This new form is a high concentrate DHA/EPA vegetarian omega-3 that is allergen and GMO free. Sourced from algae, its outstanding purity profile provides considerable sensory advantages with as much as twice the potency of other sources, such as krill oil, making it a very cost-effective choice.  

Continuing DSM’s tradition for highly interactive experiences at the show, visitors to the booth will also be able to measure the levels of lutein and zeaxanthin in their eyes. Important for protecting eyes from glare to support visual performance, FloraGLO® Lutein and OPTISHARP® Zeaxanthin form part of DSM’s eye health portfolio, which is backed by strong science.

For the first time at Vitafoods, visitors can also learn more about Fortitech® Premixes by DSM. Highlights include a market-ready powdered beverage, formulated for healthy aging. This all-in-one product was developed as an ultra-convenient way to deliver nutrients, flavors, colors, stabilizers and sweeteners in one complete powdered beverage mix. Utilizing PowerCap® technology, the premix is available both in a universal cap that fits any regular-size water bottle and as an integrated beverage system, allowing the powder to be released into a beverage at will.

Also this year, marketing thought leader Peter Wennström, renowned for his FourFactors® Brand Analysis System, will be on the DSM stand to provide his expertise to selected visitors, during one-to-one consultations.

Visitors to the stand will also be able to sample a selection of DSM’s fortified food and drinks, such as the tasty OatWell® smoothies with beta-glucan for reducing cholesterol, or relaxation chocolate bars, a rich dark chocolate infused with a custom combination of nutrients to create an indulgent, yet healthy treat.

 

 

Lallemand to debut oral care probiotics

Lallemand to debut oral care probiotics

Vitafoods Europe 2014 trade show will be the opportunity for Lallemand Health Solutions to celebrate 80 years of probiotic research and discovery with the key players of the industry! Visitors to our booth (# 19057) will have the opportunity to take part in this very special event and make their mark in probiotic history. Always looking towards the future, Lallemand Heath Solutions will also take this opportunity to introduce the latest addition to its portfolio of probiotic solutions with the launch of an innovative and promising area of applications: Oral care.

Innovative health area for probiotics
First part of the digestive system, the oral cavity also harbours a very complex, abundant and specific microflora. Lallemand Health Solutions now proposes a range of specific strains or strains combinations and galenics to help balance the oral microflora. This offer will be presented for the first time during Vitafoods Europe. Our other established health areas of applications include: gut health, immunity, stress and emotional equilibrium and women’s health.

Eighty years old and still pioneering probiotics!
This year marks the 80th anniversary of Institut Rosell, a pioneer in probiotics research and application which is at the origin of Lallemand Health Solutions. If history has proven true its founders’ vision that probiotics hold a great potential for human wellbeing and health, the company’s goal today is to look forward at the future of probiotics, to better understand their modes of action and potential benefits in emerging areas. We will also take the opportunity of this celebration to thank our trusted partners to have contributed to our success and our development over the past 80 years and hope to open the way to new partnerships to continue writing together the history of tomorrow. Visit our booth and see how you too can pioneer probiotics!

 

 

 

Nutegrity sponsors DPA symposium

Nutegrity sponsors DPA symposium

Nutegrity™ is sponsoring a symposium focused on new research surrounding DPA, an essential long-chain omega-3 fatty acid, on July 2 in Artipelag, just outside of Stockholm, Sweden. This symposium is being held in conjunction with the International Society for the Study of Fatty Acids and Lipids (ISSFAL) 2014 conference, June 28 to July 2 in Stockholm. ISSFAL brings together leading scientists in the area of lipid and fatty acid research, particularly those whose work is linked to human health.

This DPA symposium will focus on increasing the understanding of the biological effects of DPA on lipid metabolism. Presenters are prominent scientists from both academia and industry including:

  • Doug Bibus, Lipid Technologies 
  • Andrew Sinclair, Deakin University (Chair)
  • Bruce Holub, University of Guelph 
  • Edward A. Dennis, University of California, San Diego (Chair)
  • Kaisa Linderborg, University of Turku
  • Michael Ballou, Texas Tech
  • Samuel Fortin, SCF Pharma
  • Marina Lynch, Trinity College

Individuals interested in attending the ISSFAL Conference and this satellite symposium on DPA can visit issfal.org/2014/registration to register or contact their Nutegrity sales representative for more details. Early bird registration is available until March 31. 

Indena showcases Beanblock at Vitafoods

Indena showcases Beanblock at Vitafoods

In line with its tradition of a research-based company, Indena has carried out further studies on its products for the health food market and is pleased to bring to Vitafoods 2014 its latest innovative standardized bean extract of Phaseolus vulgaris L.: Beanblock®. According to the most recent clinical results, it shows high performance for the regulation of appetite and healthy blood sugar levels.

Beanblock for a well-mixed Mediterranean balanced meal
Control of body weight represents one of the most relevant targets in the management of the epidemic problem of obesity and the many health risks connected with this condition. A balanced program of dietary intervention coupled with physical activity still represents a major tool in weight control. This apparently simple and reasonable approach is by far limited in efficacy by several reasons connected with the extremely complicated metabolic network resulting in weight control.

The possibility to control dietary carbohydrates metabolism and absorption seems a very promising approach. This has been partially achieved in recent years by using the so-called starch-blockers mostly connected with the inhibition of α-amylase, the most important enzyme involved in the gastrointestinal degradation of starch.

Starting from these concerns Indena has developed Beanblock, looking at the possibility to add new values to products provided with the capacity to modulate carbohydrate metabolism and absorption.

Beanblock is a patented purified bean (Phaseolus vulgaris L.) extract obtained from a single and specific Italian bean variety (Lamon) particularly rich in α-amylase inhibitor. It is triple standardized: enzymatically - inhibiting activity U/mg:≥1.100); chemically - ≥6% (HPLC - % w/w) in α-amylase inhibitor protein complex; biologically – haemagglutinating activity ≥ 10.000 ≤ 30.000 (HAU/g). Beanblock is standardized to contain a very high amount of α-amylase inhibitor (more than 100-fold in respect of the main available products on the market) together with the proper amount of bean PHA.

Beanblock is supported and proven effective by extensive preclinical data. Moreover, acute oral administration in healthy volunteers has shown that when employed as a supplement in a mixed Mediterranean balanced meal, Banblock positively affects glucose metabolism; it also modulates ghrelin secretion and induces a longer duration of satiety, thus suggesting a potential use to control excessive food intake.

To know more, feel free to contact us, meet us at booth 17041 at Vitafoods International in Geneva and attend the seminar presentation, ”Beanbloc: a double-standardized bean extract for post-prandial blood glucose and appetite control,” on Tuesday, May 6, 15:45 to 16:15 at Seminar Theatre.

 

ConAgra posts double-digit growth

ConAgra posts double-digit growth

ConAgra Foods Inc. (NYSE: CAG), one of North America’s leading food companies, today reported results for the fiscal 2014 third quarter ended Feb. 23, 2014. Diluted EPS from continuing operations was $0.58 as reported for the fiscal third quarter vs. $0.28 in the year-ago period. After adjusting for items impacting comparability, current-quarter diluted EPS of $0.62 was 13 percent above the comparable $0.55 earned in the year-ago period. 

Gary Rodkin, ConAgra Foods’ chief executive officer, said, “We are on track with our EPS projections for the second half of this fiscal year. As we have previously discussed, there are operating challenges that have impacted segment performance and overall EPS growth, but we are encouraged by some pockets of strength. This quarter we posted good sales and market share performances for some of our consumer brands, good international growth for our potato operations, and continued improvement in the operations and organization for our private brands. The synergies expected from the former Ralcorp businesses are coming in slightly ahead of plans, and we continue to make good progress on SG&A efficiency initiatives. We reaffirm our full year fiscal 2014 EPS guidance, and remain confident in our long-term strategy and outlook.”

Consumer Foods Segment
Branded food items sold worldwide in retail channels

The Consumer Foods segment posted sales of approximately $1.9 billion and operating profit of $266 million, as reported. Sales declined, as expected, reflecting a 3 percent volume decrease and flat price/mix. The impact of foreign exchange negatively impacted segment sales by 1 percent.

  • As previously discussed, some of the volume decline in the fiscal third quarter reflects business that occurred earlier than planned in the fiscal second quarter as part of holiday promotions and changes in customer inventory levels, thus a shift in timing.
  • Brands posting sales growth for the quarter include Bertolli, Hebrew National, Reddi-wip, Ro*Tel, Slim Jim, Swiss Miss, Wolf and others. More brand details are in the Q&A document accompanying this release.
  • As previously discussed, Healthy Choice, Orville Redenbacher’s and Chef Boyardee (which collectively have annual sales in excess of $1 billion) continue to face challenges and are posting substantial volume declines. The company has important product changes, in-store initiatives, and refinements to consumer communication under way, which are expected to gradually improve the volume and profit performance of these brands throughout fiscal 2015.

Operating profit of $266 million was 1 percent above year-ago amounts as reported. After adjusting for $4 million of net expense in the current quarter and $5 million of net expense in the year-ago period from items impacting comparability, current quarter operating profit of $270 million was in line with comparable year-ago amounts. While top-line challenges weighed on profitability, several factors favorably contributed to the quarter’s profit performance, including manageable inflation, supply chain productivity initiatives, lower incentive compensation, and a strong focus on other selling, general, and administrative (SG&A) related efficiencies. Advertising and consumer promotion costs declined $15 million year-over-year, reflecting a focus on efficiency.

Commercial Foods Segment
Specialty potato, seasonings, blends, flavors, milled grain, as well as consumer branded and private branded packaged food items and bakery products, sold to foodservice and commercial channels worldwide

Sales for the Commercial Foods segment were $1.5 billion, down slightly compared with $1.5 billion a year-ago (rounded) as reported. Current-quarter sales include some benefit from acquisitions, specifically legacy Ralcorp foodservice results, which had only 27 days of contribution in year-ago amounts because of the date of the acquisition. Segment operating profit was $163 million, 12 percent below year-ago amounts as reported. After adjusting for $17 million of net expense in the current quarter and $10 million of net expense in year-ago amounts from items impacting comparability, comparable current-quarter operating profit of $180 million declined 8 percent versus $196 million a year ago.

Lamb Weston potato products’ profits were below year-ago amounts, as expected, given that a major foodservice customer did not renew a sizeable amount of potato business toward the end of last fiscal year. Lamb Weston continues to expand business with other customers; margins are lower-than-planned because of the customer mix shift as well as weaker-than-planned potato crop quality. Lamb Weston is achieving good growth internationally despite the fact that some customers are facing short-term challenges in certain Asian markets. Flour milling sales decreased, reflecting the pass-through of lower wheat costs as well as lower volumes, while milling profits increased over year-ago amounts due to favorable mix and efficiencies. Overall segment profits also reflect lower incentive compensation expense.

Private brands
Private brand food items sold in domestic markets

Sales for the Private Brands segment were $1.1 billion in the quarter, up more than $600 million over year-ago amounts. This increase reflects the acquisition of the Ralcorp businesses; sales from most of the former Ralcorp businesses are reported within this segment. Year-ago amounts include only 27 days of contribution from Ralcorp because of the date of the acquisition. Operating profit for this segment was $45 million as reported and $66 million adjusted for items impacting comparability; the increase over prior-year amounts reflects the acquisition.

As previously discussed, profitability for the Private Brands segment is below plan this fiscal year in part due to sales force and supply chain transition issues, as well as pricing actions implemented in response to competitive pressure. As part of improving connections with customers as the company works through those issues, and to remain competitive in the marketplace, the company has made deliberate pricing concessions to protect volumes; these concessions have negatively impacted margins. The margin pressures are expected to continue throughout the remainder of the fiscal year and have been reflected in the current EPS guidance. The company has made organizational, pricing, and customer service improvements that are expected to gradually improve performance over time.

Outlook
The company continues to expect fiscal 2014 diluted EPS, adjusted for items impacting comparability, to be in the range of $2.22-$2.25. The company continues to expect operating cash flow of approximately $1.4 billion in fiscal 2014, and to repay approximately $550 million of debt before the end of the fiscal year. After repaying approximately $550 million of debt in fiscal 2014, this will amount to slightly more than $950 million of cumulative net debt repayment since the acquisition of Ralcorp.

Consistent with past practice, the company will communicate details on expectations for fiscal 2015 EPS performance with the fiscal 2014 year-end release; as previously disclosed, the company expects comparable EPS growth in fiscal 2015 at a rate lower than the original double-digit target.

The company’s long-term EPS growth rates, and multi-year synergy goals related to the Ralcorp acquisition, are unchanged from prior estimates. The company expects at least 10 percent annual comparable EPS growth in the fiscal 2016-2017 period, largely due to the benefit of Ralcorp-related synergies; the company continues to expect the Ralcorp transaction to generate $300 million of annual pretax cost-related synergies by the end of fiscal 2017.

Major items impacting third-quarter fiscal 2014 EPS comparability
Included in the $0.58 diluted EPS from continuing operations for the third quarter of fiscal 2014 (EPS amounts rounded and after tax):

  • Approximately $0.08 per diluted share of net benefit, or $52 million pretax, related to the mark-to-market impact of derivatives used to hedge input costs, temporarily classified in unallocated Corporate expense. Hedge gains and losses are aggregated, and net amounts are reclassified from unallocated Corporate expense to the operating segments when the underlying commodity or foreign currency being hedged is expensed in segment cost of goods sold.
  • Approximately $0.08 per diluted share of net expense, or $55 million pretax, related to the settlement of interest rate derivative hedges that were initiated in prior years in anticipation of refinancing debt that matures in the fourth quarter of fiscal 2014. Based on an assessment of the company’s debt repayment alternatives, the company has decided to forego refinancing that debt, and has therefore recognized the derivative loss in earnings immediately.
  • Approximately $0.06 per diluted share of net expense, or $38 million pretax, resulting from restructuring and integration (including acquisition-related restructuring). $21 million of this is classified within the results of the Private Brands segment (mostly SG&A), $13 million is classified as unallocated Corporate expense (SG&A), and $4 million is classified within the Consumer Foods segment (mostly SG&A).
  • Approximately $0.04 per diluted share of net benefit due to resolving U.S. and foreign tax matters related to transactions occurring in prior years.
  • Approximately $0.02 per diluted share of net expense, or $17 million pretax, resulting from impairment of assets in the Commercial Foods segment (SG&A).

Included in the $0.28 diluted EPS from continuing operations for the third quarter of fiscal 2013 (EPS amounts rounded and after tax):

  • Approximately $0.16 per diluted share of net expense, or $103 million pretax, resulting from acquisition, acquisition-related restructuring, integration, and transaction costs. $81 million is within unallocated Corporate expense (all of which is in SG&A), $17 million is within the Private Brands results (all cost of goods sold, “COGS”) and $5 million is within Consumer Foods ($2 million in COGS, $3 million in SG&A).
  • Approximately $0.04 per diluted share of net expense, or $27 million pretax, related to the mark-to-market impact of derivatives used to hedge input costs, temporarily classified in unallocated Corporate expense. Hedge gains and losses are aggregated, and net amounts are reclassified from unallocated Corporate expense to the operating segments when the underlying commodity or foreign currency being hedged is expensed in segment cost of goods sold.
  • Approximately $0.03 per diluted share of net expense related to unusual tax matters resulting from acquisition costs.
  • Approximately $0.02 per diluted share of net expense, or $10 million pretax, related to impairment charges for assets within the Commercial Foods segment.
  • Approximately $0.01 per diluted share of net expense, or $5 million pretax, related to historical legal and environmental matters, classified within unallocated Corporate expense.

 

Expo West 2014 editor's picks: Allergen Free

"Free from" food products continued to flourish at Natural Products Expo West, and what's more, they're easily rivaling their gluten or dairy-full counterparts in taste, texture and whole-food nutrition. Newhope360.com Senior Food Editor Jenna Blumenfeld and Delicious Living Editor-in-Chief Elisa Bosley show off their favorite allergen-free finds at the show.

 

Lexicon word of the week: Antibiotic free

Lexicon word of the week: Antibiotic free

Antibiotic Free: 

A term and USDA Process Verified Unapproved label used to promote the health and welfare of food raised without subtheraputic antibiotics.  It is a also a movement generated in reaction to citizens concerned about health and environmental consequences of overuse of antibiotics in animal agriculture. 

FEATURED IN ARTWORK:

Nicolette Niman is an attorney, author and livestock rancher. She is a passionate advocate of sustainable food production.

BN Ranch, Bolinas, CA


Bill Niman is a cattle rancher and proprietor of BN Ranch, and founder of the natural meat company Niman Ranch, Inc. He was a member of the Pew Foundation’s National Commission on Industrial Farm Animal Production, which released recommendations for reform of the nation’s livestock industry in 2008.

BN Ranch, Bolinas, CA

 

RELATED DEFINITIONS:

THERAPEUTIC ANTIBIOTICS “A specific dose used for a limited period of time, in an amount calculated for an individual animal to cure a particular disease.”- Bill and Nicolette Niman, BN Ranch in Bolinas, CA

SUB-THERAPEUTIC ANTIBIOTICS “Low level dosages used for extended periods of time on otherwise healthy cattle, mainly to increase their daily weight gain.” Source: Bill and Nicolette Niman, BN Ranch in Bolinas, CA

CAFO (Concentrated Animal Feeding Operations) “Systems where livestock are kept in very crowded situation —usually in some kind of barn or facility—and fed a diet that consists mainly of grain, soybeans, and supplements (for milk cows, this include some forage like hay).” 

Peak becomes first Non-GMO Verified beer

Peak Organic Brewing Co. announced that it has become the first brewer to receive Non-GMO Project verification for its beer.

"Since day one, we've always held a simple belief—pure ingredients make delicious beer," said Jon Cadoux, founder of Peak Organic Brewing. "We love great beer, so we decided to make ours with ingredients grown on family farms that don't use chemical pesticides or fertilizers. We found those organic ingredients to be of higher quality and integrity," Cadoux added. "Organic products must be made with non-genetically modified ingredients, so we've been 'non-GMO' from the start, but we are proud to be the first brewer to receive this official designation. We're also excited to help advance the dialogue about GMOs and people's right to know if it's in the foods or drinks they are buying." 

Peak has also partnered with the Just Label It campaign, a national coalition of more than 650 organizations and 300,000 members committed to calling for mandatory labeling of genetically modified foods. Currently, 64 countries around the world require the labeling of GMO foods. The U.S. is not one of them.

The Just Label It message is simple: We consumers have a right to know what's in our food so we can make informed choices about what we buy, eat and feed our families.

"The organic seal and the Non-GMO Project verification make it crystal clear that the food and beverages on stores shelves have been produced without synthetic fertilizers, or GMO ingredients and in ways that better protect the environment," said Violet Batcha, Just Label It's communications and social media manager. "We are excited to work with Peak Brewing and other companies to continue the conversation on GMOs and labeling initiatives around the U.S."

"People want to know more about their food and drink choices, not less," says Cadoux. "They want to know what's in the products they buy, and how they are made. We think that's a great thing. We're not trying to tell people what they should eat or drink. That is up to them. When it comes to GMOs, we just think people should have the right to know, and to choose for themselves. It's really that simple."

 

Sen. Heinrich to speak at Natural Products Day breakfast

Sen. Heinrich to speak at  Natural Products Day breakfast

The industry's newest Congressional champion, Sen. Martin Heinrich, D-N.M., will be the keynote speaker at NPA's 17th Annual Natural Products Day breakfast. Please make sure to come and show Sen. Heinrich the power of our industry and the millions of constituents we serve with our products.

Sen. Heinrich was elected as the junior U.S. Senator to represent New Mexico in November 2012. He previously served two terms in the U.S. House of Representatives from 2008 to 2012, and on the Albuquerque City Council from 2003 to 2007, including one term as City Council President in 2006. A significant number of New Mexico’s residents consume dietary supplements and other natural products to address their health care needs and promote wellness. Moreover, New Mexico is home to a vibrant and growing natural products industry.

Natural Products Day will provide an opportunity to communicate to Sen. Heinrich the natural products industry’s commitment to providing high-quality products to well-informed consumers, and to protecting the freedom of choice in personal health care decisions.

This will be a lobby day you do not want to miss! Be there on April 8.